Taiwan FDA registration d526dc8c5d3daf6ee6724e5f83822523

"Abbot" Efinin C-reactive protein assay set

TW: “亞培” 艾菲寧C反應蛋白檢驗試劑組

Taiwan·Risk Class 2·ABBOTT DIAGNOSTICS TECHNOLOGIES AS·Registered Jan 08, 2021 – Jan 08, 2026Expired

Registration details

Analysis ID: d526dc8c5d3daf6ee6724e5f83822523
Customs Code: DHA05603419009

Company information

Manufacturer: ABBOTT DIAGNOSTICS TECHNOLOGIES AS
Manufacturer Country: Norway
Authorized Representative: Abbott Rapid Diagnostics Health Corp.

Product details

Intended Use: This product is used for the quantitative detection of C-reactive protein (CRP) in human whole blood, serum and plasma.
Product Type (Level 1): A Clinical Chemistry and Clinical Toxicology;; C Immunology and Microbiology
Product Type (Level 2): A.1660 Grade Material (Analysis Material Non-Analysis);; C.5270 Canti-protein immunotry system
Import Information: QMS/QSD;; 輸入

Dates and status

Registration Date: Jan 08, 2021
Expiry Date: Jan 08, 2026

About this record

Access comprehensive regulatory information for "Abbot" Efinin C-reactive protein assay set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number d526dc8c5d3daf6ee6724e5f83822523 and manufactured by ABBOTT DIAGNOSTICS TECHNOLOGIES AS. The authorized representative in Taiwan is Abbott Rapid Diagnostics Health Corp..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.